SCYNEXIS Net Income 2013-2019 | SCYX

SCYNEXIS net income from 2013 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SCYNEXIS Annual Net Income
(Millions of US $)
2018 $-12
2017 $-25
2016 $-30
2015 $-33
2014 $-6
2013 $-47
2012 $-11
SCYNEXIS Quarterly Net Income
(Millions of US $)
Q3 2019 $-8
Q2 2019 $-8
Q1 2019 $-23
Q4 2018 $2
Q3 2018 $0
Q2 2018 $-11
Q1 2018 $-4
Q4 2017 $-6
Q3 2017 $-8
Q2 2017 $-4
Q1 2017 $-6
Q4 2016 $-3
Q3 2016 $-11
Q2 2016 $-8
Q1 2016 $-7
Q4 2015 $-8
Q3 2015 $-8
Q2 2015 $-9
Q1 2015 $-6
Q4 2014 $-3
Q3 2014 $-4
Q2 2014 $2
Q1 2014 $-1
Q4 2013 $-22
Q3 2013 $-4
Q2 2013 $-3
Q1 2013 $-2
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.059B $0.000B
SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.396B 40.31
Takeda Pharmaceutical (TAK) Japan $62.093B 9.81
Astellas Pharma (ALPMY) Japan $32.356B 16.16
Eisai (ESALY) Japan $21.614B 41.67
Merck (MKGAF) Germany $16.698B 22.79
Grifols, S.A (GRFS) Spain $16.096B 21.09
Neurocrine Biosciences (NBIX) United States $9.525B 449.70
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $9.035B 36.76
Ionis Pharmaceuticals (IONS) United States $8.613B 17.44
Jazz Pharmaceuticals (JAZZ) Ireland $8.513B 10.87
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.609B 0.00
STADA ARZNEIMI (STDAF) Germany $6.004B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.349B 16.27
Arrowhead Pharmaceuticals (ARWR) United States $4.554B 68.96
Evotec AG (EVTCY) Germany $4.301B 69.51
United Therapeutics (UTHR) United States $4.056B 0.00
Nektar Therapeutics (NKTR) United States $3.893B 0.00
FibroGen (FGEN) United States $3.814B 112.08
Sage Therapeutics (SAGE) United States $3.723B 0.00
PTC Therapeutics (PTCT) United States $3.312B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.268B 12.03
ChemoCentryx (CCXI) United States $2.468B 0.00
Zogenix (ZGNX) United States $2.427B 0.00
Heron Therapeutics (HRTX) United States $2.209B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.124B 0.00
Tilray (TLRY) Canada $2.096B 0.00
Xencor (XNCR) United States $2.074B 63.03
Ironwood Pharmaceuticals (IRWD) United States $1.981B 63.15
Pacira Pharmaceuticals (PCRX) United States $1.857B 54.93
USANA Health Sciences (USNA) United States $1.709B 18.23
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.534B 10.47
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.497B 18.19
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
Endo (ENDP) Ireland $1.433B 2.63
Enanta Pharmaceuticals (ENTA) United States $1.129B 25.67
Portola Pharmaceuticals (PTLA) United States $1.086B 0.00
Karyopharm Therapeutics (KPTI) United States $1.081B 0.00
Aerie Pharmaceuticals (AERI) United States $1.033B 0.00
Dermira (DERM) United States $1.027B 0.00
Akebia Therapeutics (AKBA) United States $0.990B 0.00
Radius Health (RDUS) United States $0.882B 0.00
TherapeuticsMD (TXMD) United States $0.732B 0.00
Collegium Pharmaceutical (COLL) United States $0.727B 0.00
Flexion Therapeutics (FLXN) United States $0.703B 0.00
ImmunoGen (IMGN) United States $0.701B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.549B 0.00
Molecular Templates (MTEM) United States $0.511B 0.00
Translate Bio (TBIO) United States $0.501B 0.00
Organogenesis Holdings (ORGO) United States $0.475B 0.00
Ardelyx (ARDX) United States $0.469B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.466B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.456B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.448B 0.00
Innate Pharma SA (IPHYF) France $0.440B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.434B 18.70
Aptorum Group (APM) Hong Kong, SAR China $0.426B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.425B 51.50
Siga Technologies (SIGA) United States $0.416B 9.50
DURECT (DRRX) United States $0.408B 0.00
Lannett Co Inc (LCI) United States $0.388B 4.51
Calithera Biosciences (CALA) United States $0.382B 0.00
OptiNose (OPTN) United States $0.375B 0.00
Recro Pharma (REPH) United States $0.374B 0.00
Indivior (INVVY) United States $0.341B 1.23
Harpoon Therapeutics (HARP) United States $0.340B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.330B 0.00
Rafael Holdings (RFL) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.323B 0.00
Concert Pharmaceuticals (CNCE) United States $0.312B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Ocular Therapeutix (OCUL) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.229B 3.06
MEI Pharma (MEIP) United States $0.229B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.212B 0.00
IMV INC (IMV) Canada $0.210B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.83
Taiwan Liposome (TLC) Taiwan $0.181B 0.00
Xeris Pharmaceuticals (XERS) United States $0.166B 0.00
CannTrust Holdings (CTST) Canada $0.161B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
CV Sciences (CVSI) United States $0.120B 0.00
Otonomy (OTIC) United States $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.104B 0.00
PolarityTE (PTE) United States $0.102B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.100B 0.00
Aquestive Therapeutics (AQST) United States $0.098B 0.00
Champions Oncology (CSBR) United States $0.095B 0.00
Infinity Pharmaceuticals (INFI) United States $0.086B 0.00
Neos Therapeutics (NEOS) United States $0.086B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 22.91
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.071B 0.00
AgeX Therapeutics (AGE) United States $0.070B 0.00
Natural Alternatives (NAII) United States $0.066B 16.48
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
IsoRay (ISR) United States $0.064B 0.00
Nivalis Therapeutics (ALPN) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
VAXART, INC (VXRT) United States $0.028B 0.00
India Globalization Capital (IGC) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Heat Biologics (HTBX) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00